
Capricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue Estimates
Published on November 9, 2021
Capricor (CAPR) delivered earnings and revenue surprises of 22.73% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
